Repare Therapeutics Inc. (NASDAQ:RPTX – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 1,130,000 ...
CNL’S CNRI-H PROGRAM CONTINUES STRONG GROWTH THANKS TO NEW PROJECTS WITH REPARE THERAPEUTICS AND DEFENCE THERAPEUTICS ...
Repare and CNL plan to leverage the strengths of both organizations which cut across radiobiology, preclinical evaluation, ...
Hosted on MSN11d
Repare Therapeutics (RPTX) Loses -5.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerA downtrend has been apparent in Repare Therapeutics Inc. (RPTX) lately with too much selling pressure. The stock has ...
Canada’s national nuclear laboratories announces new projects with leading Canadian biopharmaceutical companies through collaborative research program ...
Repare and CNL plan to leverage the strengths of both organizations which cut across radiobiology, preclinical evaluation, and the discovery of therapeutics that kill cancer cells by stopping the ...
is pleased to announce that it is collaborating with two leading Canadian healthcare biotech companies – Repare Therapeutics and Defence Therapeutics – on individual research projects through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback